These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 661563)

  • 1. Effect of pyridoxine on the depletion of tissue pyridoxal phosphate by carbidopa.
    Airoldi L; Watkins CJ; Wiggins JF; Wurtman RJ
    Metabolism; 1978 Jul; 27(7):771-9. PubMed ID: 661563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N; Kuzuya F; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of carbidopa on the metabolism of L-dopa in the pigtail monkey.
    Bronaugh RL; Wenger GR; Garver DL; Rutledge CO
    Biochem Pharmacol; 1976 Jul; 25(14):1679-81. PubMed ID: 821489
    [No Abstract]   [Full Text] [Related]  

  • 4. On the mechanism of the nullification of CNS effects of L-DOPA by pyridoxine in Parkinsonian patients.
    Pfeiffer R; Ebadi M
    J Neurochem; 1972 Sep; 19(9):2175-81. PubMed ID: 5072392
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationships between pyridoxal phosphate availability, activity of vitamin B 6 -dependent enzymes and convulsions.
    Tapia R; Pasantes H
    Brain Res; 1971 Jun; 29(1):111-22. PubMed ID: 5564253
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB; Moore KE
    Life Sci; 1976 Sep; 19(5):701-6. PubMed ID: 957902
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
    Mars H
    Trans Am Neurol Assoc; 1973; 98():241-5. PubMed ID: 4784941
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of formation in vivo of pyridoxal phosphate in hydrazine-treated rats.
    Chatterjee AK; Sengupta K
    Int J Vitam Nutr Res; 1980; 50(1):24-8. PubMed ID: 7390711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
    Szabo M; Nakawatase C; Kovathana N; Frohman LA
    Neuroendocrinology; 1977; 24(1):24-34. PubMed ID: 600362
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pyridoxal 5-phosphate on carbidopa and decarboxylation of levodopa.
    Das Gupta V; Gupta A
    J Pharm Sci; 1980 Oct; 69(10):1145-8. PubMed ID: 7420279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the enzymatic blood-brain barrier: quantitative measurements of DOPA decarboxylase in the wall of microvessels as related to the parenchyma in various CNS regions.
    Hardebo JE; Falck B; Owman C; Rosengren E
    Acta Physiol Scand; 1979 Apr; 105(4):453-60. PubMed ID: 452922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
    Colamartino M; Padua L; Meneghini C; Leone S; Cornetta T; Testa A; Cozzi R
    DNA Cell Biol; 2012 Nov; 31(11):1572-9. PubMed ID: 23020119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorpromazine-induced accumulation of pyridoxal-5'-phosphate and activation of the decarboxylase of aromatic amino acids in rat brain.
    Gey KF; Burkard WP
    Ann N Y Acad Sci; 1969 Sep; 166(1):213-24. PubMed ID: 5308031
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbidopa elevates hypothalamic dopa and serum prolactin in rats.
    Watkins CJ; Wiggins JF; Wurtman RJ
    Life Sci; 1979 Apr; 24(18):1675-82. PubMed ID: 481101
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats.
    Rahman MK; Nagatsu T; Sakurai T; Hori S; Abe M; Matsuda M
    Jpn J Pharmacol; 1982 Oct; 32(5):803-11. PubMed ID: 6983619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue pyridoxal-5'-phosphate content and avoidance behavior -n 2-deoxypyridoxine-treated rats.
    Bhagavan HN; Stewart CN
    Int J Vitam Nutr Res; 1974; 44(3):357-62. PubMed ID: 4459287
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase.
    Wurtman RJ; Watkins CJ
    Nature; 1977 Jan; 265(5589):79-80. PubMed ID: 834247
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
    Männistö PT; Tuomainen P
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.